Early diagnosis of this disease is one of the factors that would enable better treatment. This is a key focus of many of the biotechnology companies that have emerged in recent decades. In Spain and in other countries, several research projects are currently underway, racing against the clock, with the aim of creating new methods for early diagnosis of Alzheimer’s disease.